Regeneron Rallies After Seeking Emergency-Use Approval For Antibody Cocktail Hailed As "Cure" By Trump


“Shares of Regeneron are ripping higher Thursday in premarket trading, building on its gains from Wednesday evening, after the company submitted its COVID-19 antibody cocktail to the FDA for emergency-use approval. The news follows President Trump's full-throated endorsement of the therapy, which the president credited for his speedy recovery, calling the treatment a "cure" for COVID-19.”

Read Our Latest News

Be the first to comment

Please check your e-mail for a link to activate your account.

This is an independent expenditure prepared and paid for by RIGHT NOW MINNESOTA, 8014 Olson Memorial HWY 55 #543 Golden Valley, MN 55427. It is not coordinated with or approved by any candidate nor is any candidate responsible for it.